Liang Mao is currently Senior Director at WuXi STA; he has joined STA for more than 7 years and now manages the developability and formulation research team. Prior to STA, Liang worked at Novartis for around 6 years in pre-formulation team supporting compound developability assessment, physical form screening and selection, preclinical formulation development. He has another 3 years work experience in research institute and Biopharmaceutical Company supporting early drug development. He has expertise in drug developability assessment, physical form screening, and bioavailability enhancement technologies. Liang holds a master’s degree in bio-chemical engineering from Nanjing University of Technology.